🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Vigonvita Life Sciences clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with Vigonvita Life Sciences as lead sponsor. Synced 26 Sep 2026
11Current trials
7Recruiting now
6Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Vigonvita Life Sciences is the lead sponsor of 11 current clinical trials in our China register. 7 are recruiting patients now. The most common phase is Phase 1. The drugs named most often in its trials are VV119, VV261 group and VV913. The most-studied condition is Healthy Volunteers.

ClinicalTrials.gov trials by status

  • Recruiting764%
  • Not yet open327%
  • Active, closed19%

Trials by phase

  • Phase 1764%
  • Phase 2327%
  • Phase EARLY_PHASE119%
01

Clinical trials sponsored by Vigonvita Life Sciences

11 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD
NCT06828887 · ClinicalTrials.gov ↗ · MDD
Phase 2 Recruiting 2025-04 China
Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119
NCT06504290 · ClinicalTrials.gov ↗ · Schizophrenia
Drug: VV119
Phase 1 Recruiting 2024-07 China
Study of Food Effects of VV913 Capsules in Chinese Healthy Volunteers
NCT07565792 · ClinicalTrials.gov ↗ · Healthy Volunteers
Drug: VV913
Phase 1 Recruiting 2026-05 China
Study of the Safety, Tolerability, Pharmacokinetics of VV913 Capsules in Chinese Healthy Participants
NCT07372703 · ClinicalTrials.gov ↗ · Healthy Volunteers
Phase 1 Recruiting 2026-01 China
Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV913 Capsules
NCT07507838 · ClinicalTrials.gov ↗ · Healthy Volunteers
Phase EARLY_PHASE1 Recruiting 2026-04 China
Study of the Safety, Tolerability, Pharmacokinetics of VV261 Tablets in Chinese Healthy Volunteers
NCT07302269 · ClinicalTrials.gov ↗ · Healthy Volunteers
Phase 1 Recruiting 2026-01 China
Study of Food Effects of VV119 Capsules in Chinese Healthy Volunteers
NCT07240636 · ClinicalTrials.gov ↗ · Healthy Volunteers
Drug: VV119
Phase 1 Recruiting 2025-11 China
Evaluate the Efficacy and Safety of VV913 Capsules in the Treatment of PE
NCT07722780 · ClinicalTrials.gov ↗ · Premature Ejaculation
Drug: VV913
Phase 2 Not yet open 2026-08 China
Evaluating Safety and Efficacy of VV119 in Acute Schizophrenia Adults
NCT07703956 · ClinicalTrials.gov ↗ · Schizophrenia
Phase 2 Not yet open 2026-07 China
Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV261 Tablets
NCT07710326 · ClinicalTrials.gov ↗ · Healthy Volunteers
Phase 1 Not yet open 2026-08 China
Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers
NCT06105151 · ClinicalTrials.gov ↗ · Schizophrenia
Drug: VV119
Phase 1 Active, closed 2023-10 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Vigonvita Life Sciences trials

6 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Vigonvita Life Sciences trials

4 conditions
Healthy Volunteers6Schizophrenia3MDD1Premature Ejaculation1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in China117

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Healthy Volunteers

SponsorTrials
Sanofi8
Bristol-Myers Squibb5
Hunan Kelun Pharmaceutical4
Shanghai Minwei Biotechnology3
Alnylam Pharmaceuticals2
Karuna Therapeutics, Inc., a Bristol Myers Squibb company2
Sanofi Pasteur, a Sanofi Company2
American Laboratory Products Company2
Xidian University2
Technical University of Munich1

Sponsors with the most current trials registered for this condition.

06

Questions about Vigonvita Life Sciences trials

How many clinical trials does Vigonvita Life Sciences sponsor?

Vigonvita Life Sciences is the lead sponsor of 11 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Vigonvita Life Sciences trials recruiting?

Yes. 7 of its 11 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Vigonvita Life Sciences testing?

Its current trials name 6 drugs and biologicals as interventions. The most frequent are VV119 (4), VV261 group (2), VV913 (2), VV913 group (2) and Aripiprazole (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.